Yes I still feel their is strong growth in GSS as well ( still holding ) but I can see AHZ and OSL both giving a better return . AHZ will go gang busters after the initial TAVR human implant and I suspect WP already has some sort of preliminary deal on the table subject to the results of the trials . The ADAPT TAVR if successful in human trials has the potential to dominate and increase the TAVR market space . Realistically younger patients will not have to go through open heart surgery like they currently do now if the longevity of ADAPT TAVR stacks up to the hype . If your interested in AHZ Silva I suggest you buy sooner rather than latter because this TAVR trial might be sooner than we all think , who knows ?
Chart predicting double prices, page-29
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.05 |
Change
-0.150(0.82%) |
Mkt cap ! $346.1M | |||
| Open | High | Low | Value | Volume |
| $18.20 | $18.29 | $18.00 | $9.989K | 552 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | $17.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.05 | 60 | 1 |
View Market Depth
| Last trade - 11.49am 09/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |